Starbucks Corp. sell BiotechBee
Start price
22.09.22
/
60%
€86.57
Target price
31.12.24
€75.00
Performance (%)
5.46%
End price
21.12.22
€91.30
Summary
This prediction ended on 21.12.22 with a price of €91.30. With a performance of 5.46%, the SELL prediction by BiotechBee for Starbucks Corp. was trending in the wrong direction Dividends of €0.53 are taken into consideration when calculating the performance. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Starbucks Corp. | 1.381% | 1.381% | -21.728% | -22.825% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
According to BiotechBee what are the pros and cons of Starbucks Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Starbucks Corp. diskutieren
Sell mit Kursziel 75,0
In the thread Trading Starbucks Corp.
Sell beendet

